Cargando…
Utilizing Estra-1,3,5,16-Tetraene Scaffold: Design and Synthesis of Nitric Oxide Donors as Chemotherapeutic Resistance Combating Agents in Liver Cancer
A new series of nitric oxide-releasing estra-1,3,5,16-tetraene analogs (NO-∆-16-CIEAs) was designed and synthesized as dual inhibitors for EGFR and MRP2 based on our previous findings on estra-1,3,5-triene analog NO-CIEA 17 against both HepG2 and HepG2-R cell lines. Among the target compounds, 14a (...
Autores principales: | Abou-Salim, Mahrous A., Shaaban, Mohamed A., Abd El Hameid, Mohammed K., Alanazi, Mohammed M., Halaweish, Fathi, Elshaier, Yaseen A. M. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055446/ https://www.ncbi.nlm.nih.gov/pubmed/36985726 http://dx.doi.org/10.3390/molecules28062754 |
Ejemplares similares
-
17α-Ethynyl-3-methoxyestra-1,3,5(10),9(11)-tetraen-17-ol
por: Li, Hongqi, et al.
Publicado: (2008) -
Crystal structure of 16-ferrocenylmethyl-3β-hydroxyestra-1,3,5(10)-trien-17-one: a potential chemotherapeutic drug
por: Carmona-Negrón, José A., et al.
Publicado: (2016) -
Estra-dimension, New Forces, And Non-newtonian Gravity
por: Fishback, E
Publicado: (2001) -
Decarboxylative and dehydrative coupling of dienoic acids and pentadienyl alcohols to form 1,3,6,8-tetraenes
por: Deiab, Ghina’a I Abu, et al.
Publicado: (2017) -
17-Deoxoestrone [estra-1,3,5(10)-trien-3-ol]–methanol (3/1)
por: Ketuly, Kamal Aziz, et al.
Publicado: (2011)